Blocking Peptides

Purity was determined to be greater than 98% by analysis by RP-HPLC and by reducing and non-reducing SDS-PAGE. Protein function: AKT2 is one of 3 closely related serine/threonine- protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through...

Purity was determined to be greater than 98% by analysis by RP-HPLC and by reducing and non-reducing SDS-PAGE. Protein function: AKT2 is one of 3 closely related serine/threonine- protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through...

To be used in conjunction with Cayman's PAF receptor polyclonal antiserum (Catalog No. 160602) to block protein-antibody complex formation during analysis for the PAF receptor.

Each vial contains 200 µg of peptide in 200 µl TBS, pH 7.4, containing 0.1% BSA and 0.02% sodium azide. The peptide is identical among human, murine, and rat optineurin, amino acids 559-575 (GEVLPDIDTLQIHVMDC). This blocking peptide can be used in conjunction with Cayman's Optineurin (C-Term) Polyclonal Antibody (Catalog No. 100000) to block protein-antibody complex...

To be used in conjunction with Cayman's optineurin (INT) polyclonal antibody (Catalog No. 100002) to block protein-antibody complex formation during analysis of optineurin.

To be used in conjunction with Cayman's HIF-1alpha Polyclonal Antibody (Cay-10006421) to block protein-antibody complex formation during immunochemical analysis of HIF-1alpha. HIF-1alpha is a transcription factor that accumulates under low-oxygen conditions. Following hypoxic stimulus and cytoplasmic accumulation, HIF-1alpha migrates to the nucleus where, with other...

To be used in conjunction with Cayman's CD36 polyclonal antibody (Catalog No. 100011) to block protein-antibody complex formation during immunochemical analysis of CD36. · CD36 is a type-B scavenger receptor that is necessary for the formation of foam cells in atherosclerotic lesions.{7719,9800, 9801,9795} This membrane glycoprotein can internalize fatty acids which activate...

To be used in conjunction with Cayman's mPGE synthase-2 polyclonal antibody (Catalog No. 160145) to block protein-antibody complex formation during analysis for microsomal PGE synthase-2.

To be used in conjunction with Cayman's beta-catenin polyclonal antibody (Catalog No. 100029) to block protein-antibody complex formation during analysis for beta-catenin.

To be used in conjunction with Cayman's Monoacylglycerol Lipase Polyclonal Antibody (Cay-100035) to block protein-antibody complex formation during analysis for monoacylglycerol lipase.

To be used in conjunction with Cayman's caveolin 1/3 polyclonal antibody (Catalog No. 100830) to block protein-antibody complex formation during analysis for Cav-1 or -3.

To be used in conjunction with Cayman's CB1 receptor polyclonal antibody (Catalog No. 101500) to block protein-antibody complex formation during analysis for the CB1 receptor. · The CB1 receptor and the splice variant CB1a are localized mainly in the brain.